180 related articles for article (PubMed ID: 20601019)
1. An integrated cardiovascular and neurobehavioural functional assessment in the conscious telemetered cynomolgus monkey.
Moscardo E; McPhie G; Fasdelli N; Giarola A; Tontodonati M; Dorigatti R; Meecham K
J Pharmacol Toxicol Methods; 2010; 62(2):95-106. PubMed ID: 20601019
[TBL] [Abstract][Full Text] [Related]
2. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
[TBL] [Abstract][Full Text] [Related]
3. An optimised neurobehavioural observation battery integrated with the assessment of cardiovascular function in the beagle dog.
Moscardo E; Fasdelli N; Giarola A; Tontodonati M; Dorigatti R
J Pharmacol Toxicol Methods; 2009; 60(2):198-209. PubMed ID: 19467338
[TBL] [Abstract][Full Text] [Related]
4. An optimised methodology for the neurobehavioural assessment in rodents.
Moscardo E; Maurin A; Dorigatti R; Champeroux P; Richard S
J Pharmacol Toxicol Methods; 2007; 56(2):239-55. PubMed ID: 17629504
[TBL] [Abstract][Full Text] [Related]
5. A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation.
Authier S; Tanguay JF; Gauvin D; Fruscia RD; Troncy E
J Pharmacol Toxicol Methods; 2007; 56(2):122-30. PubMed ID: 17587605
[TBL] [Abstract][Full Text] [Related]
6. A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 1: Non-pharmacological validation.
Authier S; Tanguay JF; Gauvin D; Di Fruscia R; Fournier S; Chaurand F; Troncy E
J Pharmacol Toxicol Methods; 2007; 56(2):115-21. PubMed ID: 17587601
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat.
Ilbäck NG; Siller M; Stålhandske T
Food Chem Toxicol; 2007 May; 45(5):834-42. PubMed ID: 17175084
[TBL] [Abstract][Full Text] [Related]
8. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
[TBL] [Abstract][Full Text] [Related]
9. Repeated assessment of cardiovascular and respiratory functions using combined telemetry and whole-body plethysmography in the rat.
Delaunois A; Dedoncker P; Hanon E; Guyaux M
J Pharmacol Toxicol Methods; 2009; 60(2):117-29. PubMed ID: 19616108
[TBL] [Abstract][Full Text] [Related]
10. Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats.
Ilbäck NG; Siller M; Stålhandske T
Lab Anim; 2008 Apr; 42(2):149-60. PubMed ID: 18435873
[TBL] [Abstract][Full Text] [Related]
11. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.
Sivarajah A; Collins S; Sutton MR; Regan N; West H; Holbrook M; Edmunds N
J Pharmacol Toxicol Methods; 2010; 62(1):12-9. PubMed ID: 20570743
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model.
Hauser DS; Stade M; Schmidt A; Hanauer G
J Pharmacol Toxicol Methods; 2005; 52(1):106-14. PubMed ID: 15961325
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
Kim TW; Kim KS; Seo JW; Park SY; Henry SP
J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
[TBL] [Abstract][Full Text] [Related]
15. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
[TBL] [Abstract][Full Text] [Related]
16. Telemetric assessment of social and single housing: Evaluation of electrocardiographic intervals in jacketed cynomolgus monkeys.
Kaiser RA; Tichenor SD; Regalia DE; York K; Holzgrefe HH
J Pharmacol Toxicol Methods; 2015; 75():38-43. PubMed ID: 25959881
[TBL] [Abstract][Full Text] [Related]
17. Measurement of hyper- and hypotension during repeated dose toxicity studies in either freely moving or physically restrained cynomolgus monkeys.
Niehoff MO; Niggemann B; Sternberg J; Jenkins A; Holbrook M
J Pharmacol Toxicol Methods; 2014; 70(3):268-75. PubMed ID: 25219539
[TBL] [Abstract][Full Text] [Related]
18. Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M
J Pharmacol Toxicol Methods; 2015; 75():44-51. PubMed ID: 25979821
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the PhysioTel™ Digital M11 cardiovascular telemetry implant in socially housed cynomolgus monkeys up to 16weeks after surgery.
Andersen NK; Meyer O; Bradley A; Dragsted N; Lassen AB; Sjögren I; Larsen JM; Harvey W; Bator R; Milne A
J Pharmacol Toxicol Methods; 2017 Sep; 87():82-92. PubMed ID: 28416413
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced effects on cardiovascular function in pentobarbital anesthetized guinea-pigs: invasive LVP measurements versus the QA interval.
Johnson DM; Geys R; Lissens J; Guns PJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):152-9. PubMed ID: 22813982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
